Early statin use after type 2 diabetes linked to 15% lower dementia risk in Danish study

COPENHAGEN - Adults who started a statin soon after a new type 2 diabetes diagnosis had lower later rates of dementia in a large Danish registry study, Fox News reported.

Researchers analyzed national health registers for about 132,585 people diagnosed with type 2 diabetes between 2006 and 2019. Median follow-up was 7.1 years. The team compared people who began a statin within one year of diagnosis with people who did not start a statin within five years. Early starters had about a 15% lower relative risk of dementia over a 10-year horizon. People who started a statin later still showed about a 10% lower relative risk versus non-users in the reported analysis.

The findings appeared in The Lancet Regional Health - Europe and were presented at the European Society of Cardiology meeting. Vascular dementia accounted for much of the measured benefit. That pattern fits the idea that cholesterol-lowering and heart-vessel protection may matter for brain blood flow, though the study design cannot prove cause and effect.

Denmark's linked prescription and hospital registers let investigators track diagnosis dates, filled statin prescriptions and later dementia codes with less missing data than many survey studies. Even so, registers cannot measure every lifestyle difference. Exercise, smoking, diet quality and family history still sit outside many administrative fields.

Dr. Liron Sinvani of Northwell Health told Fox News Digital the work is observational. People who fill statin prescriptions may also keep other appointments, control blood sugar more carefully, or differ in ways the registers cannot fully capture. Statins remain a standard tool for heart attack and stroke risk in many patients with diabetes. They are not a dementia drug by label.

Fox News noted clinicians still weigh muscle symptoms, liver tests and personal history when deciding on therapy. Guidelines already push cardiovascular risk reduction after type 2 diabetes is found, which is why many patients hear about a statin in the first year anyway. Anyone with new diabetes should ask a doctor whether a statin is appropriate for cholesterol and cardiovascular risk. Do not start or stop a statin based on dementia headlines alone.